[Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum].

Penel, N; Kouto, H; Ala-Eddine, C; Degardin, M

[Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum]. / Syndrome de lyse tumorale avec hyperuricémie symptomatique après une première cure de chimiothérapie pour carcinome indifférencié du cavum.

Penel, N; Kouto, H; Ala-Eddine, C; Degardin, M.

Rev Med Interne ; 23(3): 337-9, 2002 Mar.

Article in Fr | MEDLINE | ID: mdl-11928386

Subject(s)

Antibiotics, Antineoplastic/adverse effects; Antimetabolites, Antineoplastic/adverse effects; Antineoplastic Agents/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bleomycin/adverse effects; Carcinoma/drug therapy; Cisplatin/adverse effects; Epirubicin/adverse effects; Nasopharyngeal Neoplasms/drug therapy; Tumor Lysis Syndrome/etiology; Uric Acid/blood; Adult; Antibiotics, Antineoplastic/administration & dosage; Antimetabolites, Antineoplastic/administration & dosage; Antineoplastic Agents/administration & dosage; Bleomycin/administration & dosage; Carcinoma/diagnostic imaging; Cisplatin/administration & dosage; Epirubicin/administration & dosage; Humans; Male; Nasopharyngeal Neoplasms/diagnostic imaging; Time Factors; Tomography, X-Ray Computed; Tumor Lysis Syndrome/diagnosis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uric Acid / Bleomycin / Carcinoma / Epirubicin / Tumor Lysis Syndrome / Antineoplastic Combined Chemotherapy Protocols / Nasopharyngeal Neoplasms / Cisplatin / Antibiotics, Antineoplastic / Antimetabolites, Antineoplastic Type of study: Diagnostic_studies Limits: Adult / Humans / Male Language: Fr Journal: Rev Med Interne Year: 2002 Document type: Article Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links